- OptimizeRx (OPRX, Financial) schedules its Q1 2025 earnings conference call for May 12, 2025.
- The call will start at 4:30 p.m. Eastern Time; financial results will be released prior.
- Multiple access options for investors include toll-free, international numbers, and webcast.
OptimizeRx Corp. (Nasdaq: OPRX), a prominent provider of healthcare technology solutions, has announced that it will hold its first quarter 2025 earnings conference call on Monday, May 12, 2025. The call is scheduled to begin at 4:30 p.m. Eastern Time and will feature a detailed management presentation followed by a Q&A session.
The company will release its financial results for the quarter that ended on March 31, 2025, via press release before the commencement of the call. Investors have the flexibility to access the call through multiple channels, including a toll-free number at 1-844-825-9789 or an international dial-in at 1-412-317-5180. Additionally, a webcast option is available for broader access.
Following the live broadcast, a replay of the conference call will be made available on the company’s investor relations website for a full 12 months. This extended access ensures that shareholders and interested parties can review the detailed insights shared during the session.
OptimizeRx continues to lead in the healthcare technology sector by providing solutions that enhance engagement between life sciences companies, healthcare providers, and patients across digital platforms. This conference call marks an important opportunity for stakeholders to gain insights into the company’s recent financial performance and strategic direction.
For more information, investors are encouraged to visit the OptimizeRx website at www.optimizerx.com.
